|
|
| | BAY-1895344 Basic information |
| Product Name: | BAY-1895344 | | Synonyms: | BAY-1895344;CPD1213;(R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridin-2-yl)morpholine;BAY1895344;BAY 1895344;CPD1213;BAY1895344;BAY 1895344;BAY-1895344;1,7-Naphthyridine, 2-[(3R)-3-methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-;BAY-1895344 HCl(Elimusertib);Elimusertib free base | | CAS: | 1876467-74-1 | | MF: | C20H21N7O | | MW: | 375.43 | | EINECS: | | | Product Categories: | API | | Mol File: | 1876467-74-1.mol |  |
| | BAY-1895344 Chemical Properties |
| Melting point | >200°C (dec.) | | Boiling point | 661.1±55.0 °C(Predicted) | | density | 1.43±0.1 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly) | | pka | 11.09±0.10(Predicted) | | form | Solid | | color | Orange |
| | BAY-1895344 Usage And Synthesis |
| Uses | BAY-1895344 is a selective ATR (ataxia-telangiectasia and Rad3 related protein) inhibitor used in the treatment of advanced hyperproliferative disease, prophylaxis, solid tumors and lymphomas. |
| | BAY-1895344 Preparation Products And Raw materials |
|